Quarterly report pursuant to Section 13 or 15(d)

CollabRx Acquisition (Tables)

v2.4.0.6
CollabRx Acquisition (Tables)
 6 Months Ended
Sep. 30, 2012
CollabRx Acquisition [Abstract]  
PURCHASE PRICE ALLOCATION FOR ACQUISITION OF COLLABRX
The purchase price for the CollabRx acquisition was allocated as follows:

PURCHASE PRICE ALLOCATION FOR ACQUISITION OF COLLABRX

Assets acquired:
 
 
 
Developed Technology
 
$
720
 
Customer Relationships
 
 
433
 
Trade Name
 
 
346
 
Non Compete Agreement
 
 
151
 
Cash
 
 
476
 
AP and Accrueds
 
 
(333
 )
Deferred Tax Liability
 
 
(664
 )
Goodwill
 
 
603
 
Total Acquired Assets, net
 
$
1,732
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchase Price summary:
 
 
 
 
Common Stock Consideration
 
$
932
 
Promissory Note
 
 
500
 
Loan/Note Payable Assumed
 
 
300
 
 
$
1,732